Salivary biomarkers can help ID tongue cancer
Salivary biomarkers could improve early detection of squamous cell carcinoma of the tongue (TSCC), which has one of the poorest prognoses of head and neck
Salivary biomarkers could improve early detection of squamous cell carcinoma of the tongue (TSCC), which has one of the poorest prognoses of head and neck
Biotech firm Synedgen has been awarded a $1.96 million phase II Small Business Innovation Research grant by the National Institutes of Health (NIH) to accelerate
Finding that the availability of menthol cigarettes increases the number of children and African Americans who smoke, the U.S. Food and Drug Administration’s (FDA) Tobacco
A New York orthodontist who was sued following the death of a patient who developed tongue cancer has been found not guilty of negligence, according
Oropharyngeal (OP) cancers associated with the human papillomavirus (HPV) are increasing, especially among younger patients, but these patients have a better prognosis than those with
The discovery that a certain protein is overexpressed in patients with oral cancer may give new treatment hope to people suffering from forms of head
The VELscope oral cancer screening device (LED Dental) is useful in confirming the presence of leukoplakia and erythroplakia and other oral mucosal disorders, but has
Changes in the 2011 National Comprehensive Cancer Network (NCCN) Head and Neck Cancers Guidelines will refine and improve the treatment of these cancers, according to
The patient was insistent: All she wanted was to get her teeth whitened for an upcoming high school reunion. She came in for the $99
>Cancer diagnostics company Biomoda has been accepted as an associate member of the Early Detection Research Network (EDRN), an initiative of the National Cancer Institute
Ameritas Group, a division of Ameritas Life Insurance, has made a $250,000 gift commitment to the University of Nebraska Foundation to establish a permanent endowment
While the incidence of oropharyngeal cancer among some ethnic groups in the U.S. have declined, rates of human papillomavirus (HPV)-related oral cancer among white men